Atomwise Company
AtomNet® platform uses deep learning and convolutional neural networks for structure-based small molecule drug discovery.
Investors
.png)
%20.jpg)
.png)
.png)
Connections from
Headquarters:
USA
Founded Date:
2012
Industry:
Preclinical Development
Total Funding:
$174M